News

Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer

  • AUSTIN, Texas, July 02, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced that Melissa Moore, Ph.D., Vice President, Clinical Research and Development, will give a presentation at 11:30 a.m.
    07/02/2024

Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT

  • Greg Fuller, M.D., Ph.D., former Professor of Pathology (Neuro-Pathology) & Neuro-Radiology at The University of Texas MD Anderson Cancer Center joins Plus as Vice President of Medical Affairs and Medical Director Plus receives notice of an additional $3.3 million CPRIT advance payment for leptomeningeal cancer targeted radiotherapeutic development program AUSTIN, Texas, June 07, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announced the appointment of Dr. Greg Fuller as the Company's Vice President of Medical Affairs and Medical Director.
    06/07/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Plus Therapeutics, Inc. (PSTV) can hold. Click on Rating Page for detail.

The price of Plus Therapeutics, Inc. (PSTV) is 1.75 and it was updated on 2024-07-23 13:00:35.

Currently Plus Therapeutics, Inc. (PSTV) is in undervalued.

News
    
News

Plus Therapeutics Announces New Employment Inducement Grants

  • AUSTIN, Texas, May 17, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:  PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced that on May 8, 2024, it granted option awards to Charles Huang, the Company's new Director of Capital Markets and Investor Relations. The Company agreed to grant these equity awards to Mr.
    Fri, May. 17, 2024

Plus Therapeutics, Inc. (PSTV) Q1 2024 Earnings Call Transcript

  • Plus Therapeutics, Inc. (NASDAQ:PSTV ) Q1 2024 Earnings Conference Call May 15, 2024 5:00 PM ET Company Participants Marc Hedrick - President and Chief Executive Officer Andrew Sims - Vice President and Chief Financial Officer Norman LaFrance - Senior Vice President and Chief Medical Officer Conference Call Participants Justin Walsh - Jones Trading Edward Woo - Ascendiant Capital Sean Lee - H.C. Wainwright Operator Good afternoon, ladies and gentlemen.
    Wed, May. 15, 2024

Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

  • Announced private placement of up to $19.25M with healthcare funds and insiders Received $3M award recommendation from the Department of Defense to support Plus' clinical brain cancer program Acquired synergistic leptomeningeal metastases diagnostic portfolio and announced related positive top-line FORESEE clinical trial data Management to Host Conference Call May 15, 2024 at 5:00 p.m. ET AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc.  (Nasdaq:  PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced financial results for the first quarter ended March 31, 2024, and provided an overview of recent and upcoming business highlights.
    Wed, May. 15, 2024

Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024

  • AUSTIN, Texas, May 13, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:  PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced that the Company will report first quarter 2024 financial results on Wednesday, May 15, 2024, after market close. Plus Therapeutics' management team will then host a conference call and webcast at 5:00 p.m.
    Mon, May. 13, 2024

Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial

  • Company acquired assets for the synergistic leptomeningeal metastases (LM) diagnostic platform, “CNSide™ ” and discussed potential partnering opportunities CNSide can significantly improve LM diagnostic accuracy and the market size for Plus' lead LM radiotherapeutic candidate rhenium (Re186) obisbemeda Company summarized topline data from the FORESEE clinical trial planned for complete presentation at the SNO/ASCO Meeting in August 2024 Call replay & transcript available via the link below AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, provided highlights from its investor call regarding the rationale for the acquisition of the leptomeningeal metastases diagnostic platform “CNSide” and topline data from the FORESEE clinical trial. “Leptomeningeal metastases (LM) is significantly underdiagnosed because current tests such as MRI and cytology lack sensitivity,” said Priya U.
    Thu, May. 09, 2024
SEC Filings
SEC Filings

Plus Therapeutics, Inc. (PSTV) - ARS

  • SEC Filings
  • 07/10/2024

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/26/2024

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/15/2023

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 11/22/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/17/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/15/2023

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 11/14/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/13/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/08/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/15/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/12/2023

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 08/09/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/08/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/04/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 03/06/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/17/2023

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/04/2023

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 08/09/2022

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 08/08/2022

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/16/2022

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/06/2022

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/19/2022

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 04/28/2022

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 04/27/2022

Plus Therapeutics, Inc. (PSTV) - 4/A

  • SEC Filings
  • 03/28/2022

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 03/03/2022

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/24/2021

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 11/24/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/04/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 10/28/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 10/27/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/15/2021

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 09/03/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 07/29/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/11/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/27/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/03/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 03/05/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 03/04/2021

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 02/26/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/18/2021

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/14/2020

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/02/2020

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 10/29/2020

Plus Therapeutics, Inc. (PSTV) - S-3

  • SEC Filings
  • 10/09/2020

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/26/2020

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/14/2020

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/13/2020

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 07/01/2020

Plus Therapeutics, Inc. (PSTV) - S-8

  • SEC Filings
  • 06/30/2020

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/29/2020

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/23/2020

Plus Therapeutics, Inc. (PSTV) - D

  • SEC Filings
  • 05/22/2020

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 04/02/2020

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/14/2020

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 02/14/2020

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/10/2020

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 02/10/2020

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/22/2020

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 01/02/2020

Plus Therapeutics, Inc. (PSTV) - FWP

  • SEC Filings
  • 09/16/2019

Plus Therapeutics, Inc. (PSTV) - SD

  • SEC Filings
  • 05/30/2019

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 02/01/2019

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 09/21/2018

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 07/27/2018

Plus Therapeutics, Inc. (PSTV) - FWP

  • SEC Filings
  • 06/12/2018

Plus Therapeutics, Inc. (PSTV) - SD

  • SEC Filings
  • 05/30/2018

Plus Therapeutics, Inc. (PSTV) - CERT

  • SEC Filings
  • 05/23/2018

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 04/27/2018

Plus Therapeutics, Inc. (PSTV) - S-8

  • SEC Filings
  • 03/09/2018

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/15/2018

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/14/2018

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/12/2018

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/09/2018

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 02/01/2018

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/11/2018

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 01/08/2018

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/29/2017

Plus Therapeutics, Inc. (PSTV) - FWP

  • SEC Filings
  • 10/18/2017

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 08/14/2017

Plus Therapeutics, Inc. (PSTV) - SD

  • SEC Filings
  • 05/31/2017

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/24/2017

Plus Therapeutics, Inc. (PSTV) - S-3

  • SEC Filings
  • 05/12/2017

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 04/03/2017

Plus Therapeutics, Inc. (PSTV) - S-3

  • SEC Filings
  • 03/27/2017

Plus Therapeutics, Inc. (PSTV) - 4/A

  • SEC Filings
  • 03/17/2017

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 03/10/2017

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/27/2017

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 01/03/2017

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 12/30/2016

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 08/22/2016

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/11/2016

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/16/2016

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/15/2016

Plus Therapeutics, Inc. (PSTV) - SD

  • SEC Filings
  • 05/31/2016

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/16/2016

Plus Therapeutics, Inc. (PSTV) - FWP

  • SEC Filings
  • 05/12/2016

Plus Therapeutics, Inc. (PSTV) - S-1

  • SEC Filings
  • 04/06/2016

Plus Therapeutics, Inc. (PSTV) - S-8

  • SEC Filings
  • 03/15/2016

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 03/09/2016

Plus Therapeutics, Inc. (PSTV) - 4/A

  • SEC Filings
  • 02/05/2016

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/01/2016

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/04/2016

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/13/2015

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 10/15/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/08/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/03/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/31/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/28/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/25/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/24/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/21/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/20/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/19/2015

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 08/19/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/12/2015

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 08/12/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/18/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/14/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 04/20/2015

Plus Therapeutics, Inc. (PSTV) - S-8

  • SEC Filings
  • 03/18/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/25/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/13/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/03/2015

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/13/2014

Plus Therapeutics, Inc. (PSTV) - S-3

  • SEC Filings
  • 11/12/2014

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/12/2014

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/04/2014

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 09/04/2014

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/22/2014

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 07/02/2014

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 07/02/2014

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/12/2014

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 06/12/2014

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/09/2014

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/20/2014

Plus Therapeutics, Inc. (PSTV) - S-3

  • SEC Filings
  • 05/09/2014

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 04/15/2014

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 02/10/2014

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/14/2014

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/03/2014

Plus Therapeutics, Inc. (PSTV) - S-3

  • SEC Filings
  • 11/19/2013

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 10/09/2013

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 10/09/2013

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/16/2013

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/11/2013

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/09/2013

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/05/2013

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/03/2013

Plus Therapeutics, Inc. (PSTV) - ARS

  • SEC Filings
  • 08/01/2013

Plus Therapeutics, Inc. (PSTV) - 4/A

  • SEC Filings
  • 02/13/2013

Plus Therapeutics, Inc. (PSTV) - 5

  • SEC Filings
  • 02/12/2013

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/04/2013

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/03/2013

Plus Therapeutics, Inc. (PSTV) - 4/A

  • SEC Filings
  • 12/21/2012

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/21/2012

Plus Therapeutics, Inc. (PSTV) - S-8

  • SEC Filings
  • 05/30/2012

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 03/14/2012

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/06/2012

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/30/2012

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/04/2012

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/15/2011

Plus Therapeutics, Inc. (PSTV) - 4/A

  • SEC Filings
  • 12/14/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/14/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/08/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/28/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/17/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/16/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/15/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/23/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/15/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/12/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/25/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/03/2011

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 05/03/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/02/2011

Plus Therapeutics, Inc. (PSTV) - S-3

  • SEC Filings
  • 03/11/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 03/01/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/03/2011

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 02/03/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/31/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/04/2011

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/23/2010

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/03/2010

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 11/03/2010

Plus Therapeutics, Inc. (PSTV) - FWP

  • SEC Filings
  • 10/08/2010

Plus Therapeutics, Inc. (PSTV) - FWP

  • SEC Filings
  • 10/07/2010

Plus Therapeutics, Inc. (PSTV) - ARS

  • SEC Filings
  • 06/28/2010

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/07/2010

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/24/2010

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/21/2010

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/19/2010

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/10/2010

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/09/2010

Plus Therapeutics, Inc. (PSTV) - 4/A

  • SEC Filings
  • 01/22/2010

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 01/21/2010

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/21/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/25/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/24/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/18/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/17/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/12/2009

Plus Therapeutics, Inc. (PSTV) - D

  • SEC Filings
  • 06/30/2009

Plus Therapeutics, Inc. (PSTV) - ARS

  • SEC Filings
  • 06/29/2009

Plus Therapeutics, Inc. (PSTV) - S-3

  • SEC Filings
  • 06/11/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/20/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/19/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/18/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/11/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 05/04/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/02/2009

Plus Therapeutics, Inc. (PSTV) - S-3

  • SEC Filings
  • 01/30/2009

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/01/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/24/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/20/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/18/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 10/14/2008

Plus Therapeutics, Inc. (PSTV) - S-3

  • SEC Filings
  • 08/28/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/14/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/12/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/11/2008

Plus Therapeutics, Inc. (PSTV) - ARS

  • SEC Filings
  • 07/15/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/20/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/18/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/17/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/16/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/12/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/11/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 06/10/2008

Plus Therapeutics, Inc. (PSTV) - 4/A

  • SEC Filings
  • 02/11/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/04/2008

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/21/2007

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 12/21/2007

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/30/2007

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/19/2007

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 08/24/2007

Plus Therapeutics, Inc. (PSTV) - 3/A

  • SEC Filings
  • 05/09/2007

Plus Therapeutics, Inc. (PSTV) - 3/A

  • SEC Filings
  • 04/05/2007

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 02/28/2007

Plus Therapeutics, Inc. (PSTV) - FWP

  • SEC Filings
  • 02/26/2007

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/14/2006

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/13/2006

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/11/2006

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/08/2006

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 12/06/2006

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/30/2006

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/28/2006

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 11/22/2006

Plus Therapeutics, Inc. (PSTV) - 3

  • SEC Filings
  • 11/17/2006

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/11/2006

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/07/2006

Plus Therapeutics, Inc. (PSTV) - 4

  • SEC Filings
  • 09/05/2006